Covid-19 roundup: Serum Institute chief asks countries to 'please be patient'; Sanofi and GlaxoSmithKline enter PhII with 'refined' vaccine formulation
Serum Institute of India CEO Adar Poonawalla has asked countries waiting for doses of AstraZeneca and Oxford University’s vaccine to “please be patient,” as the manufacturer has been directed to prioritize India’s needs.
The Serum Institute is the world’s largest vaccine manufacturer by volume, according to Reuters. It’s producing hundreds of millions of doses of the AstraZeneca/Oxford vaccine, which it branded COVISHIELD.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 102,900+ biopharma pros reading Endpoints daily — and it's free.